Raymond James & Associates’s Invesco Dorsey Wright Healthcare Momentum ETF PTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $260K | Sell |
5,605
-19,162
| -77% | -$869K | ﹤0.01% | 3481 |
|
|
2024
Q2 | $1.06M | Sell |
24,767
-13,742
| -36% | -$577K | ﹤0.01% | 2585 |
|
|
2024
Q1 | $1.69M | Buy |
+38,509
| New | +$1.63M | ﹤0.01% | 2269 |
|
|
2023
Q4 | – | Sell |
-6,134
| Closed | -$206K | – | 3924 |
|
|
2023
Q3 | $206K | Sell |
6,134
-871
| -12% | -$32.2K | ﹤0.01% | 3432 |
|
|
2023
Q2 | $284K | Buy |
7,005
+195
| +3% | +$7.76K | ﹤0.01% | 3289 |
|
|
2023
Q1 | $255K | Sell |
6,810
-2,472
| -27% | -$96.7K | ﹤0.01% | 3352 |
|
|
2022
Q4 | $381K | Sell |
9,282
-9,282
| -50% | -$377K | ﹤0.01% | 3066 |
|
|
2022
Q3 | $750K | Buy |
18,564
+6,627
| +56% | +$280K | ﹤0.01% | 2568 |
|
|
2022
Q2 | $457K | Sell |
11,937
-95,859
| -89% | -$3.87M | ﹤0.01% | 2972 |
|
|
2022
Q1 | $4.83M | Sell |
107,796
-14,001
| -11% | -$613K | ﹤0.01% | 1537 |
|
|
2021
Q4 | $6.29M | Sell |
121,797
-912
| -0.7% | -$47.4K | 0.01% | 1398 |
|
|
2021
Q3 | $6.59M | Buy |
122,709
+85,173
| +227% | +$4.77M | 0.01% | 1319 |
|
|
2021
Q2 | $2.08M | Buy |
37,536
+414
| +1% | +$21.5K | ﹤0.01% | 2065 |
|
|
2021
Q1 | $1.94M | Sell |
37,122
-51,552
| -58% | -$2.89M | ﹤0.01% | 2032 |
|
|
2020
Q4 | $4.73M | Sell |
88,674
-4,515
| -5% | -$225K | 0.01% | 1373 |
|
|
2020
Q3 | $4.22M | Buy |
93,189
+8,427
| +10% | +$372K | 0.01% | 1318 |
|
|
2020
Q2 | $3.45M | Buy |
84,762
+4,644
| +6% | +$164K | ﹤0.01% | 1414 |
|
|
2020
Q1 | $2.28M | Buy |
80,118
+68,292
| +577% | +$2.08M | ﹤0.01% | 1496 |
|
|
2019
Q4 | $377K | Sell |
11,826
-4,059
| -26% | -$115K | ﹤0.01% | 2937 |
|
|
2019
Q3 | $414K | Sell |
15,885
-15,117
| -49% | -$433K | ﹤0.01% | 2790 |
|
|
2019
Q2 | $911K | Sell |
31,002
-84,135
| -73% | -$2.26M | ﹤0.01% | 2271 |
|
|
2019
Q1 | $3.06M | Sell |
115,137
-42,180
| -27% | -$1.11M | ﹤0.01% | 1504 |
|
|
2018
Q4 | $3.73M | Sell |
157,317
-102,381
| -39% | -$2.76M | 0.01% | 1247 |
|
|
2018
Q3 | $8.55M | Buy |
259,698
+108,780
| +72% | +$3.37M | 0.01% | 918 |
|
|
2018
Q2 | $4.4M | Buy |
150,918
+7,125
| +5% | +$198K | 0.01% | 1271 |
|
|
2018
Q1 | $3.65M | Sell |
143,793
-45,312
| -24% | -$1.17M | 0.01% | 1324 |
|
|
2017
Q4 | $4.54M | Buy |
189,105
+20,316
| +12% | +$468K | 0.01% | 1175 |
|
|
2017
Q3 | $3.81M | Buy |
168,789
+80,694
| +92% | +$1.7M | 0.01% | 1229 |
|
|
2017
Q2 | $1.82M | Sell |
88,095
-31,944
| -27% | -$590K | ﹤0.01% | 1628 |
|
|
2017
Q1 | $2.15M | Buy |
120,039
+24,537
| +26% | +$425K | 0.01% | 1478 |
|
|
2016
Q4 | $1.53M | Sell |
95,502
-120,120
| -56% | -$1.95M | ﹤0.01% | 1660 |
|
|
2016
Q3 | $3.79M | Sell |
215,622
-189,720
| -47% | -$3.08M | 0.01% | 1087 |
|
|
2016
Q2 | $6.04M | Buy |
405,342
+179,898
| +80% | +$2.68M | 0.02% | 763 |
|
|
2016
Q1 | $3.25M | Sell |
225,444
-62,766
| -22% | -$906K | 0.01% | 1033 |
|
|
2015
Q4 | $5.29M | Sell |
288,210
-319,563
| -53% | -$5.88M | 0.02% | 785 |
|
|
2015
Q3 | $11M | Buy |
607,773
+34,407
| +6% | +$714K | 0.04% | 455 |
|
|
2015
Q2 | $12.1M | Buy |
573,366
+343,629
| +150% | +$7.1M | 0.05% | 451 |
|
|
2015
Q1 | $4.64M | Sell |
229,737
-179,403
| -44% | -$3.45M | 0.02% | 778 |
|
|
2014
Q4 | $7.4M | Buy |
409,140
+179,118
| +78% | +$3.1M | 0.04% | 517 |
|
|
2014
Q3 | $3.81M | Sell |
230,022
-11,577
| -5% | -$188K | 0.02% | 760 |
|
|
2014
Q2 | $3.95M | Buy |
241,599
+36,015
| +18% | +$555K | 0.02% | 742 |
|
|
2014
Q1 | $3.28M | Buy |
+205,584
| New | +$3.39M | 0.02% | 762 |
|
Other funds holding PTH
SA
IWM
SAM
JIP
Raymond James & Associates's PTH Position: Q3 2024 in Review
Raymond James & Associates reduced its Invesco Dorsey Wright Healthcare Momentum ETF (PTH) stake by 77% in Q3 2024, selling an estimated $869K and leaving 5,605 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #3481.
Raymond James & Associates first reported a position in PTH in Q1 2014 and has held it in 42 quarters since. The position peaked at $12.1M in Q2 2015. 64 funds tracked by Wall St. Rank hold PTH as of Q3 2024.
- Raymond James & Associates held 5,605 shares of Invesco Dorsey Wright Healthcare Momentum ETF worth $260K as of Q3 2024.
- Raymond James & Associates sold 19,162 Invesco Dorsey Wright Healthcare Momentum ETF shares in Q3 2024, an estimated $869K.
- Invesco Dorsey Wright Healthcare Momentum ETF made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3481 holding.
- Raymond James & Associates first reported a position in Invesco Dorsey Wright Healthcare Momentum ETF in Q1 2014 and has held it in 42 quarters since.
- Raymond James & Associates's Invesco Dorsey Wright Healthcare Momentum ETF position peaked at $12.1M in Q2 2015.
- 64 funds tracked by Wall St. Rank held Invesco Dorsey Wright Healthcare Momentum ETF as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.